Bob 1 Rabbit Polyclonal Antibody

Bob 1 Rabbit Polyclonal Antibody

To Order Contact Us Below:

    Bob 1 Polyclonal Antibody
    ES8740-100ul 100ul
    EUR 334.8
    Description: A Rabbit Polyclonal antibody against Bob 1 from Human. This antibody is tested and validated for IHC, WB, ELISA
    Bob 1 Polyclonal Antibody
    ES8740-50ul 50ul
    EUR 248.4
    Description: A Rabbit Polyclonal antibody against Bob 1 from Human. This antibody is tested and validated for IHC, WB, ELISA
    Bob 1 Polyclonal Conjugated Antibody
    C46860 100ul
    EUR 476.4
    BOB-1 Antibody
    R30579 100 ug
    EUR 419
    HRP-Goat Anti-Rabbit Secondary Antibody
    A12004
    • EUR 232.26
    • EUR 117.70
    • 350 µg
    • 350 ug
    Goat Anti-Rabbit Secondary Antibody, Biotin Conjugated
    A12001
    • EUR 232.26
    • EUR 117.70
    • 350 µg
    • 350 ug
    Anti-Bob 1 antibody
    STJ98803 200 µl
    EUR 236.4
    Description: Rabbit polyclonal to Bob 1.
    Anti-BOB.1 antibody
    STJ180019 0.1 ml
    EUR 306
    POU2AF1 Antibody / BOB-1
    F55017-0.08ML 0.08 ml
    EUR 165
    POU2AF1 Antibody / BOB-1
    F55017-0.4ML 0.4 ml
    EUR 379
    POU2AF1 Antibody / BOB-1
    V3902-100UG 100 ug
    EUR 499
    Description: BOB-1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB-1. Conversely, only some cases of classical Hodgkin lymphoma show BOB-1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB-1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity.
    POU2AF1 Antibody / BOB-1
    V3902-20UG 20 ug
    EUR 219
    Description: BOB-1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB-1. Conversely, only some cases of classical Hodgkin lymphoma show BOB-1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB-1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity.
    POU2AF1 Antibody / BOB-1
    V3902SAF-100UG 100 ug
    EUR 499
    Description: BOB-1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB-1. Conversely, only some cases of classical Hodgkin lymphoma show BOB-1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB-1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity.
    POU2AF1 Antibody / BOB-1
    V3903-100UG 100 ug
    EUR 499
    Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity.
    POU2AF1 Antibody / BOB-1
    V3903-20UG 20 ug
    EUR 219
    Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity.
    POU2AF1 Antibody / BOB-1
    V3903SAF-100UG 100 ug
    EUR 499
    Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity.
    POU2AF1 Antibody / BOB-1
    V3915-100UG 100 ug
    EUR 499
    Description: Transcriptional coactivator that specifically associates with either OCT1 or OCT2. It boosts the OCT1 mediated promoter activity and to a lesser extent, that of OCT2. It has no intrinsic DNA-binding activity. It recognizes the POU domains of OCT1 and OCT2. It is essential for the response of B-cells to antigens and required for the formation of germinal centers. [UniProt]
    POU2AF1 Antibody / BOB-1
    V3915-20UG 20 ug
    EUR 219
    Description: Transcriptional coactivator that specifically associates with either OCT1 or OCT2. It boosts the OCT1 mediated promoter activity and to a lesser extent, that of OCT2. It has no intrinsic DNA-binding activity. It recognizes the POU domains of OCT1 and OCT2. It is essential for the response of B-cells to antigens and required for the formation of germinal centers. [UniProt]
    POU2AF1 Antibody / BOB-1
    V3915SAF-100UG 100 ug
    EUR 499
    Description: Transcriptional coactivator that specifically associates with either OCT1 or OCT2. It boosts the OCT1 mediated promoter activity and to a lesser extent, that of OCT2. It has no intrinsic DNA-binding activity. It recognizes the POU domains of OCT1 and OCT2. It is essential for the response of B-cells to antigens and required for the formation of germinal centers. [UniProt]
    POU2AF1 Antibody / BOB-1
    V3918-100UG 100 ug
    EUR 499
    Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity.
    POU2AF1 Antibody / BOB-1
    V3918-20UG 20 ug
    EUR 219
    Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity.
    POU2AF1 Antibody / BOB-1
    V3918SAF-100UG 100 ug
    EUR 499
    Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity.
    POU2AF1 Antibody / BOB-1
    V7324-100UG 100 ug
    EUR 499
    Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity.
    POU2AF1 Antibody / BOB-1
    V7324-20UG 20 ug
    EUR 219
    Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity.
    POU2AF1 Antibody / BOB-1
    V7324IHC-7ML 7 ml
    EUR 499
    Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity.
    POU2AF1 Antibody / BOB-1
    V7324SAF-100UG 100 ug
    EUR 499
    Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity.
    POU2AF1 Antibody / BOB-1
    V8023-100UG 100 ug
    EUR 499
    Description: BOB.1 expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB.1. Conversely, only some cases of classical Hodgkin lymphoma show BOB.1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB.1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity.
    POU2AF1 Antibody / BOB-1
    V8023-20UG 20 ug
    EUR 219
    Description: BOB.1 expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB.1. Conversely, only some cases of classical Hodgkin lymphoma show BOB.1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB.1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity.
    POU2AF1 Antibody / BOB-1
    V8023SAF-100UG 100 ug
    EUR 499
    Description: BOB.1 expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB.1. Conversely, only some cases of classical Hodgkin lymphoma show BOB.1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB.1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity.
    Polyclonal BOB / GPR15 Antibody (Cytoplasmic Domain)
    AMM05631G 0.05mg
    EUR 580.8
    Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human BOB / GPR15 (Cytoplasmic Domain). This antibody is tested and proven to work in the following applications:
    Polyclonal BOB / GPR15 Antibody (Extracellular Domain)
    AMM05632G 0.05mg
    EUR 580.8
    Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human BOB / GPR15 (Extracellular Domain). This antibody is tested and proven to work in the following applications:
    BOB.1 MonoSpecific Antibody, Unconjugated-20ug
    5450-MSM4-P0 20ug
    EUR 279.6
    BOB.1 MonoSpecific Antibody, Unconjugated-100ug
    5450-MSM4-P1 100ug
    EUR 513.6
    Histone H3K4 Methylation Antibody Panel Pack
    C10005
    • EUR 754.26
    • EUR 470.80
    • 3 x 25 µg
    • 3 x 25 ul
    Histone H3K9 Methylation Antibody Panel Pack
    C10006
    • EUR 754.26
    • EUR 470.80
    • 3 x 25 µg
    • 3 x 25 ul
    Histone H3K27 Methylation Antibody Panel Pack
    C10007
    • EUR 754.26
    • EUR 470.80
    • 3 x 25 µg
    • 3 x 25 ul
    Histone H3K36 Methylation Antibody Panel Pack
    C10008
    • EUR 754.26
    • EUR 470.80
    • 3 x 25 µg
    • 3 x 25 ul
    Histone H3K79 Methylation Antibody Panel Pack
    C10009
    • EUR 754.26
    • EUR 470.80
    • 3 x 25 µg
    • 3 x 25 ul
    Histone H4K20 Methylation Antibody Panel Pack
    C10012
    • EUR 754.26
    • EUR 470.80
    • 3 x 25 µg
    • 3 x 25 ul
    Histone H4 Acetylation Antibody Panel Pack
    C10013
    • EUR 754.26
    • EUR 470.80
    • 4 x 25 µg
    • 4 x 25 ul
    Histone H3 Phosphorylation Antibody Panel Pack
    C10014
    • EUR 754.26
    • EUR 470.80
    • 3 x 25 µg
    • 3 x 25 ul
    Histone H3R2 Methylation Antibody Panel Pack
    C10015
    • EUR 754.26
    • EUR 470.80
    • 3 x 25 µg
    • 3 x 25 ul
    Histone H3R8 Methylation Antibody Panel Pack
    C10016
    • EUR 754.26
    • EUR 470.80
    • 3 x 25 µg
    • 3 x 25 ul
    Histone H3R17 Methylation Antibody Panel Pack
    C10017
    • EUR 754.26
    • EUR 470.80
    • 3 x 25 µg
    • 3 x 25 ul
    Histone H3R26 Methylation Antibody Panel Pack
    C10018
    • EUR 754.26
    • EUR 470.80
    • 3 x 25 µg
    • 3 x 25 ul
    Histone H4R3 Methylation Antibody Panel Pack
    C10019
    • EUR 754.26
    • EUR 470.80
    • 3 x 25 µg
    • 3 x 25 ul
    HRP-Goat Anti-Mouse Secondary Antibody
    A12003
    • EUR 232.26
    • EUR 117.70
    • 350 µg
    • 350 ug
    DNA Methylation Antibody Panel Pack I
    C20000
    • EUR 458.46
    • EUR 270.60
    • each
    • 2 x 25 ul
    Histone H3 Acetylation Antibody Panel Pack I
    C10010
    • EUR 928.26
    • EUR 588.50
    • 4 x 25 µg
    • 4 x 25 ul
    Histone H3 Acetylation Antibody Panel Pack II
    C10011
    • EUR 928.26
    • EUR 588.50
    • 4 x 25 µg
    • 4 x 25 ul
    Goat Anti-Rat Secondary Antibody, Biotin Conjugated
    A12002
    • EUR 232.26
    • EUR 117.70
    • 350 µg
    • 350 ug
    Histone H3 Methylation Antibody Panel Pack I – Active Genes
    C10000
    • EUR 928.26
    • EUR 588.50
    • 4 x 25 µg
    • 4 x 25 ul
    Histone H3 Methylation Antibody Panel Pack I – Repression Genes
    C10001
    • EUR 928.26
    • EUR 588.50
    • 4 x 25 µg
    • 4 x 25 ul
    Histone H3 Methylation Antibody Panel Pack II – Active Genes
    C10002
    • EUR 754.26
    • EUR 470.80
    • 3 x 25 µg
    • 3 x 25 ul
    Histone H3 Methylation Antibody Panel Pack II – Repression Genes
    C10003
    • EUR 928.26
    • EUR 588.50
    • 4 x 25 µg
    • 4 x 25 ul
    Histone H3 Methylation Antibody Panel Pack III – Active Genes
    C10004
    • EUR 928.26
    • EUR 588.50
    • 4 x 25 µg
    • 4 x 25 ul
    Rabbit Polyclonal Antibody to Human Topoisomerase IIα
    TG2011-1 250 units
    EUR 496.8
    BOB.1 (B-Cell Marker) (BOB1/2423) Antibody
    BNC042423-100 100uL
    EUR 279.6
    Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF405S conjugate, Concentration: 0.1mg/mL
    BOB.1 (B-Cell Marker) (BOB1/2423) Antibody
    BNC042423-500 500uL
    EUR 654
    Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF405S conjugate, Concentration: 0.1mg/mL
    BOB.1 (B-Cell Marker) (BOB1/2424) Antibody
    BNC042424-100 100uL
    EUR 279.6
    Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF405S conjugate, Concentration: 0.1mg/mL
    BOB.1 (B-Cell Marker) (BOB1/2424) Antibody
    BNC042424-500 500uL
    EUR 654
    Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF405S conjugate, Concentration: 0.1mg/mL
    BOB.1 (B-Cell Marker) (BOB1/2425) Antibody
    BNC042425-100 100uL
    EUR 279.6
    Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF405S conjugate, Concentration: 0.1mg/mL

    Bob 1 Rabbit Polyclonal Antibody

    Scroll to Top